首页> 外国专利> METHOD FOR EARLY PROGNOSIS OF RISK OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS SUFFERING FROM CORONARY HEART DISEASE AFTER MYOCARDIAL REVASCULARIZATION BY CORONARY ARTERY BYPASS SURGERY

METHOD FOR EARLY PROGNOSIS OF RISK OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS SUFFERING FROM CORONARY HEART DISEASE AFTER MYOCARDIAL REVASCULARIZATION BY CORONARY ARTERY BYPASS SURGERY

机译:冠状动脉搭桥术引起的心律失常后冠心病患者的血栓性新陈代谢并发症的风险的早期预测方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medical diagnostics and discloses a method for early prognosis of risk of thromboembolic complications in patients suffering from coronary heart disease after myocardial revascularization by coronary artery bypass surgery (CABG). Method comprises determining the level of tumor necrosis factor-α (TNF-α), interleukin-10 (IL-10) and metalloproteinase-1 (MMP-1) in the blood serum using a solid-phase enzyme-linked immunosorbent assay, characterized in that if the IL-10 concentration is higher than 65 pg/ml in the preoperative period and higher than 320 pg/ml in the 1st day after operation, concentration of TNF-α is higher than 24 pg/ml in the preoperative period and MMP-1 concentration is higher 3.3 ng/ml in the preoperative and postoperative period, a high risk of thromboembolic complications after CABG surgery is predicted.;EFFECT: method allows in a short time after operation to predict the risk of thromboembolic complications and to adopt the necessary strategy for therapy of this disease state.;1 cl, 2 ex, 2 dwg, 1 tbl
机译:发明领域本发明涉及医学诊断,并公开了通过冠状动脉搭桥术(CABG)在心肌血运重建后患有冠心病的患者中血栓栓塞并发症的风险的早期预后的方法。该方法包括使用固相酶联免疫吸附法测定血清中肿瘤坏死因子-α(TNF-α),白介素-10(IL-10)和金属蛋白酶-1(MMP-1)的水平,如果术前IL-10的浓度高于65 pg / ml,而在手术后的第一天高于320 pg / ml,则TNF-α的浓度高于24术前pg / ml和MMP-1浓度在术前和术后均高于3.3 ng / ml,预示CABG手术后血栓栓塞并发症的高风险。效果:该方法可在术后短时间内预测血栓栓塞并发症的风险,并采取必要的策略来治疗这种疾病。; 1 cl,2 ex,2 dwg,1 tbl

著录项

获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号